Not all ultra-processed foods are made alike: Researchers warn against villainizing entire food group

Researchers find that ultra-processed food (UPF) consumption may not be directly responsible for poor health outcomes, with lifestyle factors playing a significant role. More experimental research is needed to establish causality.

FDA Approves Another SGLT2 Inhibitor for Treating CKD

The SGLT2 inhibitor empagliflozin (Jardiance) nabbed a new indication for the treatment of adults with chronic kidney disease (CKD) regardless of diabetes status, Boehringer Ingelheim

September 23, 2023

Twin Health Secures $52M to Expand Whole Body Digital Twin Tech

What You Should Know: Twin Health, creators of the Whole Body Digital Twin™ service for reversing, improving, and preventing chronic metabolic diseases, announced securing $50 million

December 14, 2023

Astellas seeks approval for PADCEV-KEYTRUDA combo

Share this article The sNDA is based on the Phase III EV-302 clinical trial. Credit: totojang1977/ shutterstock.com. Astellas Pharma has submitted a supplemental new drug

January 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.